Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Circ Cardiovasc Genet. 2017 Aug;10(4):e001613. doi: 10.1161/CIRCGENETICS.116.001613

Figure 2.

Figure 2

Information seeking and sharing. a, Internet use and EHR/PHR access at baseline and/or 3 and 6 months after risk disclosure, with significant p-values (*P<0.05) for the mean difference between values at 3 and 6 months post-disclosure; shared decision-making for statin initiation and documentation of subsequently lowered LDL-c levels in the chart are completed by or at 3 months post-disclosure, prior to observation of significant changes in information seeking and sharing survey responses between the CRS and GRS groups from 3 to 6 months post-disclosure. b, Information sharing at 3 months post-disclosure, with significant p-values (*P<0.05) for the mean difference between values at 3 and 6 months post-disclosure. c, Sharing radius (see Figure S3) at 3 months post-disclosure, with distribution skewed towards a maximum score Σ=4 for GRS participants. d, The time course of statin use and lowering of LDL-C levels in CRS and GRS participants potentially mirrors significant changes in information seeking and sharing; LDL-C decreased from baseline significantly more in GRS participants, due to higher statin use relative to CRS participants. CHD = coronary heart disease; CRS = conventional risk score; EHR = electronic health record; GRS = genetic risk score; LDL-C = serum calculated low density lipoprotein; PHR = personal health record.